Skip to Content
Global News Select

Tech Companies Join Effort Focused on Covid-19 Vaccine Records

By Micah Maidenberg 

Businesses including Microsoft Corp., Oracle Corp. and Cerner Corp. are working with health groups on an effort to help people easily show they have received a Covid-19 vaccine.

The companies and organizations, including Mayo Clinic, are behind the Vaccination Credential Initiative, which aims to ensure consumers can access their vaccination records as the economy opens back up and daily life returns to more normal conditions following the pandemic.

The effort is meant to help people demonstrate their vaccination status so they can "safely return to travel, work, school, and life, while protecting their data privacy," said Paul Meyer, chief executive of the Commons Project Foundation, another group involved in the project.

People who don't have smartphones could receive printouts that have QR codes that can be scanned to show their vaccination status, he said.

Health groups that participate in the effort will agree to provide people with digital access to the records using common software standards. Mike Sicilia, executive vice president of Oracle's Global Business Units, said accessing data for vaccinations, testing and other medical records needs to be as simple as online banking.

Write to Micah Maidenberg at


(END) Dow Jones Newswires

January 14, 2021 11:15 ET (16:15 GMT)

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.